Plain-English translation of NCT05571514 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether mother-of-pearl supplementation can help prevent bone loss in postmenopausal women at risk for osteoporosis. Mother-of-pearl is a natural substance that contains calcium and may have additional bone-protective effects beyond regular calcium supplements. The study will compare this treatment to standard calcium carbonate supplementation to see which is more effective at slowing bone loss.
After menopause, women lose bone density quickly, which can lead to osteoporosis and broken bones. Researchers want to know whether this medication offers better bone protection than standard calcium supplements alone.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to take either mother-of-pearl capsules or standard calcium carbonate capsules — both groups will also receive vitamin D. You will take your assigned capsules daily at home. The study will track your bone health over time to compare how well each treatment works at preventing bone loss in postmenopausal women.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
France